We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+1.76%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.83B
AUM Growth
+$108M
(+2.3%)
Cap. Flow
+$83.9M
Cap. Flow
% of AUM
1.74%
Top 10 Holdings %
Top 10 Hldgs %
12.94%
Holding
1,335
New
249
Increased
372
Reduced
442
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$35.5M |
| 2 |
CVS Health
CVS
|
+$32.5M |
| 3 |
Biogen
BIIB
|
+$24.9M |
| 4 |
Citigroup
C
|
+$23.8M |
| 5 |
PAY
Verifone Systems Inc
PAY
|
+$21.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Targa Resources
TRGP
|
+$31.7M |
| 2 |
Comcast
CMCSA
|
+$23.5M |
| 3 |
Verizon
VZ
|
+$23.2M |
| 4 |
Amazon
AMZN
|
+$22.2M |
| 5 |
Eli Lilly
LLY
|
+$22.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.34% |
| 2 | Financials | 15.76% |
| 3 | Healthcare | 13.7% |
| 4 | Industrials | 10.3% |
| 5 | Consumer Discretionary | 10.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
United Therapeutics
UTHR
$26.5B
| $2.57M | 0.05% |
24,278
+14,878
| +158% | +$1.66M |
|
|
BHI
377
DELISTED
Baker Hughes
BHI
| $2.56M | 0.05% |
+56,770
| New | +$2.57M |
|
|
AD
378
Array Digital Infrastructure
AD
$3.02B
| $2.56M | 0.05% |
65,072
+59,372
| +1,042% | +$2.36M |
|
379
CVR Energy
CVI
$3.38B
| $2.55M | 0.05% |
164,438
+85,607
| +109% | +$1.81M |
|
|
SIGM
380
DELISTED
Sigma Designs Inc
SIGM
| $2.52M | 0.05% |
391,161
-5,100
| -1% | -$33.9K |
|
|
MANT
381
DELISTED
Mantech International Corp
MANT
| $2.51M | 0.05% |
66,473
+370
| +0.6% | +$12.7K |
|
|
AMCC
382
DELISTED
Applied Micro Circuits Corporation New
AMCC
| $2.51M | 0.05% |
390,807
-16,500
| -4% | -$105K |
|
|
NMBL
383
DELISTED
Nimble Storage, Inc.
NMBL
| $2.51M | 0.05% |
+314,849
| New | +$2.45M |
|
384
International Flavors & Fragrances
IFF
$19.4B
| $2.49M | 0.05% |
+19,760
| New | +$2.44M |
|
385
Argan
AGX
$8.14B
| $2.45M | 0.05% |
+58,802
| New | +$2.11M |
|
386
UFP Industries
UFPI
$4.96B
| $2.45M | 0.05% |
79,200
+45,690
| +136% | +$1.29M |
|
387
Magnite
MGNI
$2.67B
| $2.43M | 0.05% |
178,108
+134,450
| +308% | +$2.16M |
|
388
Stepan Co
SCL
$1.32B
| $2.37M | 0.05% |
39,835
| – | – |
|
|
AGN
389
DELISTED
Allergan plc
AGN
| $2.36M | 0.05% |
+10,230
| New | +$2.36M |
|
390
National Bank Holdings
NBHC
$1.96B
| $2.35M | 0.05% |
115,376
+33,000
| +40% | +$672K |
|
391
Andersons Inc
ANDE
$2.63B
| $2.34M | 0.05% |
65,935
+45,735
| +226% | +$1.5M |
|
|
SHOR
392
DELISTED
ShoreTel, Inc.
SHOR
| $2.34M | 0.05% |
349,336
+3,000
| +0.9% | +$19.9K |
|
393
Calix
CALX
$2.3B
| $2.33M | 0.05% |
337,813
-11,800
| -3% | -$80.7K |
|
|
SJI
394
DELISTED
South Jersey Industries, Inc.
SJI
| $2.33M | 0.05% |
+73,675
| New | +$2.11M |
|
395
RenaissanceRe
RNR
$13.6B
| $2.32M | 0.05% |
19,784
+5,327
| +37% | +$611K |
|
396
Precigen
PGEN
$1.93B
| $2.31M | 0.05% |
+94,796
| New | +$2.69M |
|
397
John Wiley & Sons Class A
WLY
$2.51B
| $2.29M | 0.05% |
43,840
-5,910
| -12% | -$298K |
|
398
DigitalBridge
DBRG
$2.93B
| $2.29M | 0.05% |
+56,007
| New | +$2.66M |
|
|
WGL
399
DELISTED
Wgl Holdings
WGL
| $2.29M | 0.05% |
32,290
+15,730
| +95% | +$1.07M |
|
|
VTLE
400
DELISTED
Vital Energy
VTLE
| $2.28M | 0.05% |
10,898
-18,297
| -63% | -$4.03M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2016 Portfolio in Review
As of Q2 2016, Jacobs Levy Equity Management held 1,335 positions worth $4.83B, up 2.3% from $4.72B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management's Q2 2016 filing shows 249 new, 372 increased, 442 reduced and 194 closed positions. Its largest new stake was CVS Health: 325,716 shares worth $31.2M. The largest sale was Targa Resources, an estimated $31.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Jacobs Levy Equity Management's largest Q2 2016 buy was CVS Health: 325,716 shares worth $31.2M.
- Jacobs Levy Equity Management added most to Microsoft in Q2 2016, an estimated $35.5M increase.
- Jacobs Levy Equity Management's biggest Q2 2016 reduction was Comcast, cutting an estimated $23.5M.
- Jacobs Levy Equity Management fully exited Targa Resources in Q2 2016, selling an estimated $31.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $4.83B portfolio in Q2 2016.
- Jacobs Levy Equity Management opened 249 new positions and closed 194 in Q2 2016.
- Jacobs Levy Equity Management's portfolio value rose 2.3% quarter-over-quarter to $4.83B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2016, filed 15 Aug 2016.